Oct 30, 2024 8:00am EDT LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024
Oct 27, 2024 9:00pm EDT CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100
Oct 21, 2024 8:00am EDT LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
Sep 30, 2024 8:00am EDT LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences
Aug 12, 2024 8:00am EDT LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
Aug 07, 2024 4:01pm EDT LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024